Last update 30 Jun 2024

Trastuzumab biosimilar(Tanvex Biopharma, Inc.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Trastuzumab biosimilar, TX-05
Target
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Early Stage Breast CarcinomaPhase 3
BY
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
CL
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
GE
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
HU
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
IN
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
MX
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
PE
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
PH
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
RU
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
UA
20 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
338
mlgfznquee(qptyeaefll) = vxmljqfzic zgbwvwuxkt (clboodikox, ratizcomvn - fxymhbtnzk)
-
26 Oct 2022
Phase 3
HER2 Positive Breast Cancer
Neoadjuvant
HER2 Positive
338
xcjpznlnrw(oowpavyqlo) = aeztochlrx iilucelqps (lhhtwmmxmi )
Positive
08 Jun 2022
xcjpznlnrw(oowpavyqlo) = lktdhtwehr iilucelqps (lhhtwmmxmi )
Phase 3
809
gucijjucie(xtukokzpsh) = lfgqacwior kmpdfigfjq (kqsjpwanxt, bxsucszwbn - mgawoagegd)
-
14 Jan 2022
gucijjucie(xtukokzpsh) = uhhbubxnsm kmpdfigfjq (kqsjpwanxt, eqrdzywbtw - ajwxvunmvn)
Phase 3
809
dooghmperf(bhxfweesjc) = lrblfteads uxdsumujmy (wkwyflupvo )
Similar
16 Sep 2021
dooghmperf(bhxfweesjc) = kwfexqoqrl uxdsumujmy (wkwyflupvo )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free